MEDICINAL PLANTS FOR LIVER DISORDERS IN EASTERN MEDICINE: PHARMACOGNOSTIC AND PHARMACOLOGICAL PERSPECTIVES

Authors

Keywords:

Avicenna; al-Razi; al-Biruni; medicinal plants; pharmacognosy; natural products; hepatoprotection; pharmacology; medicinal chemistry; toxicology; liver disease.

Abstract

Medicinal plants and naturally derived compounds have played an important role in the historical development of therapeutics and continue to represent a valuable source of bioactive molecules for modern pharmacology and medicinal chemistry. The scientific heritage of Abu Bakr al-Razi, Abu Ali ibn Sina (Avicenna), and Abu Rayhan al-Biruni contains extensive information on medicinal substances historically used in disorders associated with the liver and digestive system. The aim of this narrative review was to reassess selected liver-related therapeutic concepts described in their works from the contemporary perspectives of pharmacognosy, pharmacology, medicinal and pharmaceutical chemistry, toxicology, and biochemistry. Historical medical and pharmaceutical sources were considered together with contemporary scientific publications addressing hepatoprotective medicinal plants, phytochemical constituents, molecular mechanisms of hepatic injury, herbal safety, and pharmaceutical standardization. Modern analysis of Avicenna’s Canon of Medicine has identified 163 plant species belonging to 73 botanical families that were historically associated with liver and spleen disorders, together with approximately 30 non-herbal remedies. Al-Biruni’s Kitab al-Saydana fi al-Tibb contributed to the systematic identification, description, origin, quality assessment, and substitution of medicinal substances, whereas al-Razi emphasized clinical observation and therapeutic experience. Contemporary evidence indicates that plant-derived flavonoids, phenolic compounds, alkaloids, terpenoids, glycosides, saponins, and related metabolites may modulate oxidative stress, inflammatory signaling, lipid metabolism, mitochondrial dysfunction, cell death, and fibrogenic pathways involved in liver injury. However, most evidence remains preclinical, and historical use cannot be regarded as proof of modern clinical efficacy or safety. The scientific translation of historical materia medica therefore requires botanical authentication, phytochemical profiling, pharmacological and biochemical validation, toxicological assessment, pharmaceutical standardization, pharmacokinetic evaluation, and well-designed clinical studies.

References

1.Gonfa YH, Bachheti A, Semwal P, Rai N, Singab AN, Bachheti RK. Hepatoprotective activity of medicinal plants, their phytochemistry, and safety concerns: a systematic review. Z Naturforsch C J Biosci. 2025;80(3–4):61–73. doi:10.1515/znc-2024-0116.

2.Thilagavathi R, Begum SS, Varatharaj SD, Balasubramaniam AK, George JS, Selvam C. Recent insights into the hepatoprotective potential of medicinal plants and plant-derived compounds. Phytother Res. 2023;37(5):2102–2118. doi:10.1002/ptr.7821.

3.Huang L, Tan L, Lv Z, Chen W, Wu J. Pharmacology of bioactive compounds from plant extracts for improving non-alcoholic fatty liver disease through endoplasmic reticulum stress modulation: a comprehensive review. Heliyon. 2024;10(3):e25053. doi:10.1016/j.heliyon.2024.e25053.

4.Datta S, Aggarwal D, Sehrawat N, et al. Hepatoprotective effects of natural drugs: current trends, scope, relevance and future perspectives. Phytomedicine. 2023;121:155100. doi:10.1016/j.phymed.2023.155100.

5.Bjørklund G, Cruz-Martins N, Goh BH, et al. Medicinal plant-derived phytochemicals in detoxification. Curr Pharm Des. 2024;30(13):988–1015. doi:10.2174/1381612829666230809094242.

6.Shahkarami E, Minaei B, Dehkordi Jafari E. The concept of liver disease diagnosis in Avicenna’s Canon of Medicine. Iran J Public Health. 2013;42(7):785–786.

7.Ghobadi Pour M, Mirazi N, Seif A. Treatment of liver and spleen illnesses by herbs: recommendations of Avicenna’s heritage “Canon of Medicine”. Avicenna J Phytomed. 2019;9(2):101–116.

8.Klein-Junior LC, de Souza MR, Viaene J, et al. Quality control of herbal medicines: from traditional techniques to state-of-the-art approaches. Planta Med. 2021;87(12–13):964–988. doi:10.1055/a-1529-8339.

9.Liao Y, Lv F, Quan T, Wang C, Li J. Flavonoids in natural products for the therapy of liver diseases: progress and future opportunities. Front Pharmacol. 2024;15:1485065. doi:10.3389/fphar.2024.1485065.

10.New drug discovery and development from natural products: advances and strategies. Pharmacol Ther. 2024:108752. doi:10.1016/j.pharmthera.2024.108752.

11.Liang Y, Qiu S, Zou Y, Luo L. Targeting ferroptosis with natural products in liver injury: new insights from molecular mechanisms to targeted therapies. Phytomedicine. 2024.

12.Medicinal herbs and their metabolites with biological potential to protect and combat liver toxicity and its disorders: a review. 2024. PMID: 38356556.

13.Tighe SP, Akhtar D, Iqbal U, Ahmed A. Chronic liver disease and silymarin: a biochemical and clinical review. J Clin Transl Hepatol. 2020;8(4):454–458. doi:10.14218/JCTH.2020.00012.

14.Malik A, Malik M, Qureshi S. Effects of silymarin use on liver enzymes and metabolic factors in metabolic dysfunction-associated steatotic liver disease: a systematic review and meta-analysis. Can Liver J. 2024;7(1):40–53. doi:10.3138/canlivj-2023-0021.

15.Li S, Duan F, Li S, Lu B. Administration of silymarin in NAFLD/NASH: a systematic review and meta-analysis. Ann Hepatol. 2024;29(2):101174. doi:10.1016/j.aohep.2023.101174.

16.Natural products in non-alcoholic fatty liver disease: novel lead discovery for drug development. Pharmacol Res. 2023;106925. doi:10.1016/j.phrs.2023.106925.

17.Natural products in pursuing novel therapies of nonalcoholic fatty liver disease and steatohepatitis. 2023. PMID: 36610488.

18.Natural PPARs agonists for the treatment of nonalcoholic fatty liver disease. Biomed Pharmacother. 2022;151:113127. doi:10.1016/j.biopha.2022.113127.

19.Herb-induced liver injury: systematic review and meta-analysis. 2021. PMID: 34307603.

20.Mahdavi Jafari J, Aliasl J, Ehsani MJ, Kamalinejad M, Gachkar L, Choopani R. Traditional Iranian medicine: the use of the Canon of Medicine by Avicenna to treat ascites. Eur J Integr Med. 2015;7(6):674–678. doi:10.1016/j.eujim.2015.08.009.

Published

2026-09-21